lobbying_activities: 2605105

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2605105	06672678-0605-437c-852f-8bad538c1d8a	Q1	MUSCULAR DYSTROPHY ASSOCIATION, INC.	400348610	MUSCULAR DYSTROPHY ASSOCIATION, INC.	2021	first_quarter	PHA	Advocated for provisions that enable ongoing access to necessary medications and treatments for neuromuscular disease patients throughout theCOVID-19 pandemic. Advocated for the reintroduction of the ACT for ALS, legislation that should accelerate development of treatments for individuals with ALS and other neuromuscular diseases.	Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Federal Aviation Administration (FAA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Transportation, Dept of (DOT)		100000	0	0	2021-04-19T16:10:09.200000-04:00